CME Outfitters

10/12/2026

Hosted by Dr. Singh and Dr. Avery
Credit+Info https://cmeo.me/MM-169

10/12/2026

💡 Every diagnostic decision matters.

Discover how evidence-based assessments can help distinguish idiopathic hypersomnia from other hypersomnolence disorders and support more personalized patient care.

👉 https://cmeo.me/MMV-163

Idiopathic hypersomnia (IH) is a life-disrupting condition characterized by excessive daytime sleepiness (EDS) that makes waking up a daily struggle, limits productivity, and erodes overall quality of life. For many patients with IH, the journey to...

10/11/2026

🌍 Health equity starts with recognizing disparities.

Systemic barriers, racial bias, and social drivers of health continue to affect patient outcomes across therapeutic areas. Explore findings from Phase 2 of this educational initiative and discover practical strategies to help advance equitable care.

👉 https://cmeo.me/CN-048

Systemic health inequities disproportionately impact underserved racial and ethnic populations, leading to higher morbidity, mortality, and reduced quality of life. Socioeconomic disadvantages, racial bias, and barriers to care contribute to these disparities, yet they often go unnoticed...

10/11/2026

🚨 We're LIVE in 15 minutes!

There's still time to join Beyond VEGF from wherever you are.

Explore blood-retinal barrier biology and emerging mechanisms in DME and nAMD with expert faculty.

🕖 8:00 PM ET
💻 Livestream

👉 Join us: https://cmeo.me/MMS-169

Anti-vascular endothelial growth factor (anti-VEGF) therapy transformed the management of diabetic macular edema (DME) and neovascular age-related macular degeneration (nAMD), but it has not solved either disease. Roughly 40% to 60% of patients with DME and...

10/11/2026

⏰ We're LIVE in 1 hour!

Join retina specialists and other eye care professionals online for Beyond VEGF and explore:

👁️ Blood-retinal barrier biology
🔬 Emerging therapeutic mechanisms
🩺 Incomplete anti-VEGF response in DME and nAMD

🕖 8:00 PM ET

💻 Join the livestream: https://cmeo.me/MMS-169

Anti-vascular endothelial growth factor (anti-VEGF) therapy transformed the management of diabetic macular edema (DME) and neovascular age-related macular degeneration (nAMD), but it has not solved either disease. Roughly 40% to 60% of patients with DME and...

10/11/2026

👁️💻 Today's the day!

Tune in to Beyond VEGF for a closer look at blood-retinal barrier biology, emerging therapeutic mechanisms, and strategies for patients with suboptimal anti-VEGF response.

🕖 Tonight | 8:00 PM ET
📺 Livestream

👉 Register: https://cmeo.me/MMS-169

Anti-vascular endothelial growth factor (anti-VEGF) therapy transformed the management of diabetic macular edema (DME) and neovascular age-related macular degeneration (nAMD), but it has not solved either disease. Roughly 40% to 60% of patients with DME and...

10/11/2026

⏰ Tomorrow at 8:30 PM ET!

Can't join us in Nashville? Tune in via livestream for Beyond the Bowel: Addressing Obesity as a Modifiable Driver of IBD Outcomes.

Work through real-world cases and explore:
✔️ Visceral and mesenteric adiposity
✔️ IBD treatment response and surgical risk
✔️ Validated adiposity assessment
✔️ GLP-1 RAs and individualized weight management

💻 Register: https://cmeo.me/MMS-167

Obesity is transforming the landscape of inflammatory bowel disease (IBD), shaping disease activity, treatment response, and long-term prognosis. As evidence reveals the impact of excess weight on biologic and JAK inhibitor effectiveness, emerging anti-obesity therapies, including...

10/10/2026

⏱️ Timely treatment saves lives.

Delays in diagnosing and treating viral hepatitis (HBV, HCV, HDV) remain common across the globe. This CME Outfitters Snack explores practical ways to reduce time to treatment initiation by improving screening and diagnostic pathways.
🔗 https://cmeo.me/SN-274

This global discussion among experts in Asia, Europe, and North America focuses on reducing delays in treatment for hepatitis B (HBV), hepatitis C (HCV), and hepatitis D (HDV) by addressing current gaps in screening, including the...

10/10/2026

Understanding patients’ social needs is essential for effective chronic disease management 📊❤️.

Learn how to screen for food insecurity and connect patients with nutrition resources that support better long-term health.
Watch the activity: https://cmeo.me/SN-250

Food insecurity and other negative social drivers of health (SDOH) impact health outcomes in underserved communities. Screening for food insecurity using validated tools has proven to be an essential part of healthcare interventions to connect patients...

10/10/2026

⏰ Tomorrow at 8:00 PM ET!

Tune in via livestream for Beyond VEGF.

Explore the mechanisms driving blood-retinal barrier breakdown, emerging therapeutic approaches, and practical strategies for recognizing incomplete anti-VEGF response in DME and nAMD.

💻 Join us online: https://cmeo.me/MMS-169

Anti-vascular endothelial growth factor (anti-VEGF) therapy transformed the management of diabetic macular edema (DME) and neovascular age-related macular degeneration (nAMD), but it has not solved either disease. Roughly 40% to 60% of patients with DME and...